未消化麦醇溶蛋白肽GLIADIN P31-43

未消化麦醇溶蛋白肽GLIADIN P31-43

中文名称未消化麦醇溶蛋白肽GLIADIN P31-43
中文同义词未消化麦醇溶蛋白肽GLIADIN P31-43
英文名称L-Tyrosine, L-leucylglycyl-L-glutaminyl-L-glutaminyl-L-glutaminyl-L-prolyl-L-phenylalanyl-L-prolyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-prolyl-
英文同义词L-Tyrosine, L-leucylglycyl-L-glutaminyl-L-glutaminyl-L-glutaminyl-L-prolyl-L-phenylalanyl-L-prolyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-prolyl-;Gliadin p31-43
CAS号176326-01-5
分子式C71H102N18O20
分子量1527.68
EINECS号
相关类别
Mol文件176326-01-5.mol
结构式未消化麦醇溶蛋白肽GLIADIN P31-43 结构式

未消化麦醇溶蛋白肽GLIADIN P31-43 性质

沸点1968.7±65.0 °C(Predicted)
密度1.371±0.06 g/cm3(Predicted)
形态固体
酸度系数(pKa)3.11±0.10(Predicted)
颜色白色至米白色

未消化麦醇溶蛋白肽GLIADIN P31-43 用途与合成方法

Gliadin p31-43 是一种未消化的麦醇溶蛋白肽,可诱导肠道内的先天性免疫反应并干扰内吞运输。Gliadin p31-43 可用于乳糜泻的研究。

Gliadin p31-43 (100 μg/mL; 30 minutes-6 hours) treatment induces the MyD88/TLR7 complexes, and activates downstream signalling by activating MAPKs, ERK, JNK and p38). Gliadin p31-43 increases the levels of the phosphorylated forms of pY-ERK, JNK (pY-JNK) and p38 (pY-p38).
Gliadin p31-43 treatment increases NF-κB phosphorylation in CaCo-2 cells from 0.45 in control cells to 0.86. Gliadin p31-43 treatment induces a significant increase in levels of the MxA protein. The levels of the IFN-α 7 and 17 mRNAs are also analysed after Gliadin p31-43 treatment.
In CaCo-2 cells, Gliadin p31-43 localizes to the early endosomes and delays vesicular trafficking. Gliadin p31-43 interferes with the correct localization of the growth factor regulated tyrosine kinase substrate (HRS) to early endosomes, delaying the maturation of the endocytic vesicles.

Western Blot Analysis

Cell Line: CaCo-2 cells
Concentration: 100 μg/mL
Incubation Time: 30 minutes, 3 hours, 6 hours
Result: Showed the increase in formation of the MyD88/TLR7 complex, and increased in the level of TLR7.

Gliadin p31-43 (10 μg; intraluminally injection) shows a sequence-specific spontaneous ability to form structured oligomers and aggregates in vitro and induced activation of the apoptosis-associated speck-like (ASC) complex.
The increment of IL-1β indicates the activation of the inflammasome caspase-1 pathway in the small intestine mucosa by oral administration of Gliadin p31-43 (20 μg) in wild type C57Bl/6 mice. Gliadin p31-43 has an intrinsic propensity to form oligomers which trigger the NLRP3 inflammasome.

安全信息

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2024/01/25HY-P3151Gliadin p31-431 mg2200元
2024/01/25HY-P3151Gliadin p31-43176326-01-55 mg5500元

未消化麦醇溶蛋白肽GLIADIN P31-43 上下游产品信息

"未消化麦醇溶蛋白肽GLIADIN P31-43"相关产品信息
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》